Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep887 | Reproductive and Developmental Endocrinology | ECE2022

Assessment of a new marker of polycystic ovary syndrome in morbidly obese women

Oueslati Ibtissem , Terzi Amani , Hammami Bassem , Hassen Hana Belhadj , Boukriba Seif , Mizouni Habiba , Feki Moncef , Chihaoui Melika

Introduction: Polycystic ovary syndrome is the most common cause of anovulatory infertility in women. Anti-Mullerian Hormone (AMH) was considered a reliable marker for the diagnosis of polycystic ovary syndrome (PCOS). However, AMH level is influenced by age and body mass index. The aim of this study was to analyze the performance of the (LH x AMH)/FSH ratio in the diagnosis of PCOS in women with morbid obesity.Methods: This was a cross-sectional study i...

ea0063ep45 | Diabetes, Obesity and Metabolism | ECE2019

Insulin resistance and metabolic disorders in women with morbid obesity

Boukhayatia Fatma , Oueslati Ibtissem , Hassen Hana Belhadj , Hammami Bassem , Grira Wafa , Feki Moncef , Chaker Fatma , Chihaoui Melika

Introduction: Metabolic abnormalities are usually linked with obesity. However, a proportion of obese individuals might not be at an increased risk of metabolic complications of obesity and therefore their phenotype can be referred to as metabolically healthy obesity. The aim of our study was to evaluate the metabolic status in women with morbid obesity and to determine its association with insulin resistance.Methods: In a cross sectional study, we enrol...

ea0063ep46 | Diabetes, Obesity and Metabolism | ECE2019

Prevalence of non alcoholic fatty liver disease in women with morbid obesity

Boukhayatia Fatma , Oueslati Ibtissem , Hassen Hana Belhadj , Hammami Bassem , Boukriba Seif , Chaker Fatma , Yazidi Meriem , Mizouni Habiba , Chihaoui Melika

Introduction: Obesity related disease complications reduce life quality and expectancy and increase health care costs. Non-alcoholic fatty liver disease (NAFLD) is one of the major complications associated with obesity and is considered to be the hepatic manifestation of the metabolic syndrome. Our objective was to determine the prevalence of the NAFLD and to identify its clinical and biological associated factors in women with morbid obesity.Methods: Th...